Dean Y Li

Executive VP & President, MRL

Dean Y Li (Executive VP & President, MRL) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Merck & Co., Inc. (MRK). The largest single filing was $1.8M of MRK (15,087 sh × $118.77, as filed), executed Feb 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.0M

shares × price, as filed

Last traded

Feb 10

Filed Feb 10

Median ADV $1.4B across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

MRK

Merck & Co., Inc. MRK · 0 buys · 2 sells 2 filings

Recent filings

MRKSALE Merck & Co., Inc. View filing → $1.2M
10,235 sh × $117.52
Exec Feb 10
Filed Feb 10 · 5:30 PM ET MRKSALE Merck & Co., Inc. View filing → $1.8M
15,087 sh × $118.77
Exec Feb 4
Filed Feb 6 · 5:30 PM ET